Drug Type Small molecule drug |
Synonyms LTP 001, LTP-001 |
Target |
Mechanism SMURF1 antagonists(SMAD specific E3 ubiquitin protein ligase 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization |
---|---|---|---|
Pulmonary Arterial Hypertension | Phase 2 | NL More | |
Idiopathic Pulmonary Fibrosis | Phase 2 | - | |
Lung Diseases | Pending | CH More | Novartis AG More |